受强制性开放获取政策约束的文章 - Ellen Zwarthoff了解详情
无法在其他位置公开访问的文章:6 篇
FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study
W Beukers, KA van der Keur, R Kandimalla, Y Vergouwe, EW Steyerberg, ...
The Journal of urology 197 (6), 1410-1418, 2017
强制性开放获取政策: Government of Spain
FGFR3 mutation status and FGFR3 expression in a large bladder cancer cohort treated by radical cystectomy: implications for anti-FGFR3 treatment?
BWG van Rhijn, LS Mertens, R Mayr, PJ Bostrom, FX Real, EC Zwarthoff, ...
European Urology 78 (5), 682-687, 2020
强制性开放获取政策: Dutch Cancer Society
FGFR3 and PIK3CA mutations are involved in the molecular pathogenesis of solar lentigo
C Hafner, R Stoehr, JMM Van Oers, EC Zwarthoff, F Hofstaedter, ...
British Journal of Dermatology 160 (3), 546-551, 2009
强制性开放获取政策: Cancer Research UK
Absence of BRAF and HRAS mutations in eruptive Spitz naevi
S Gantner, T Wiesner, L Cerroni, I Lurkin, EC Zwarthoff, M Landthaler, ...
British Journal of Dermatology 164 (4), 873-877, 2011
强制性开放获取政策: German Research Foundation
Muscle invasive bladder cancer: a single sample patient assay to predict molecular subtypes and benefit of neoadjuvant chemotherapy
R Seiler, HAD Ashab, N Erho, BW Van Rhijn, B Winters, J Douglas, ...
European Urology Supplements 3 (16), e1567-e1568, 2017
强制性开放获取政策: Swiss National Science Foundation, Netherlands Organisation for Scientific …
MP59-03 A URINE-BASED MUTATION-METHYLATION ASSAY FOR THE SURVEILLANCE OF HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS
J de Jong, F de Jong, A Ziel-van der Made, T Hagdorn, E Boevé, ...
Journal of Urology 207 (Supplement 5), e1001, 2022
强制性开放获取政策: Netherlands Organisation for Health Research and Development
可在其他位置公开访问的文章:63 篇
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
强制性开放获取政策: US Department of Defense, US National Institutes of Health
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
强制性开放获取政策: US Department of Defense, US National Institutes of Health
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
强制性开放获取政策: US National Institutes of Health
Comprehensive molecular characterization of muscle-invasive bladder cancer
AG Robertson, J Kim, H Al-Ahmadie, J Bellmunt, G Guo, AD Cherniack, ...
Cell 171 (3), 540-556. e25, 2017
强制性开放获取政策: US Department of Defense, US National Institutes of Health
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
强制性开放获取政策: US National Institutes of Health
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
强制性开放获取政策: US National Institutes of Health
Machine learning identifies stemness features associated with oncogenic dedifferentiation
TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ...
Cell 173 (2), 338-354. e15, 2018
强制性开放获取政策: US National Institutes of Health, US Department of Veterans Affairs …
Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas
TA Knijnenburg, L Wang, MT Zimmermann, N Chambwe, GF Gao, ...
Cell reports 23 (1), 239-254. e6, 2018
强制性开放获取政策: US Department of Defense, US National Institutes of Health
Genomic and functional approaches to understanding cancer aneuploidy
AM Taylor, J Shih, G Ha, GF Gao, X Zhang, AC Berger, SE Schumacher, ...
Cancer cell 33 (4), 676-689. e3, 2018
强制性开放获取政策: US National Institutes of Health
Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images
J Saltz, R Gupta, L Hou, T Kurc, P Singh, V Nguyen, D Samaras, ...
Cell reports 23 (1), 181-193. e7, 2018
强制性开放获取政策: US National Science Foundation, US National Institutes of Health
The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma
CJ Ricketts, AA De Cubas, H Fan, CC Smith, M Lang, E Reznik, R Bowlby, ...
Cell reports 23 (1), 313-326. e5, 2018
强制性开放获取政策: US National Institutes of Health
Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy
R Seiler, HAD Ashab, N Erho, BWG van Rhijn, B Winters, J Douglas, ...
European urology 72 (4), 544-554, 2017
强制性开放获取政策: Swiss National Science Foundation, US National Institutes of Health …
Comprehensive analysis of alternative splicing across tumors from 8,705 patients
A Kahles, KV Lehmann, NC Toussaint, M Hüser, SG Stark, ...
Cancer cell 34 (2), 211-224. e6, 2018
强制性开放获取政策: US National Institutes of Health, Federal Ministry of Education and Research …
Pathogenic germline variants in 10,389 adult cancers
K Huang, RJ Mashl, Y Wu, DI Ritter, J Wang, C Oh, M Paczkowska, ...
Cell 173 (2), 355-370. e14, 2018
强制性开放获取政策: US National Institutes of Health
出版信息和资助信息由计算机程序自动确定